3D Cell Culture

Global Market Trajectory & Analytics

MCP10010

EXECUTIVE ENGAGEMENTS

POOL

2193
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

393
Interactions with Platform & by Email

PARTICIPANTS

66
Unique # Participated

VALIDATIONS

22
Responses Validated*

COMPANIES

38
Responses Validated*
* Login for a full stack data experience

DATE

MAY 2021

TABLES

125

PAGES

150

EDITION

8

PRICE

USD 4950

CODE

MCP10010


COMPETITIVE METRICS

COMPANY

D S N T

% *

3D Biotek, LLC

Login Required

Abc biopply

Login Required

ABER Instruments Ltd.

Login Required

Advanced BioMatrix, Inc.

Login Required

Agilent Technologies, Inc.

Login Required

AMS Biotechnology (Europe) Ltd. (amsbio)

Login Required

Beckman Coulter, Inc.

Login Required

Becton, Dickinson and Company

Login Required

BellBrook Labs

Login Required

Biogelx Ltd.

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 38 COMPETITORS

Sign-in with email to View Deeper Validated Engagement Details -

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for 3D Cell Culture estimated at US$972.1 Million in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 13.7% over the analysis period 2020-2027.Scaffold-based, one of the segments analyzed in the report, is projected to grow at a 13.9% CAGR to reach US$1.1 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Scaffold-free segment is readjusted to a revised 13.1% CAGR for the next 7-year period. This segment currently accounts for a 27.2% share of the global 3D Cell Culture market.
The 3D Cell Culture market in the U.S. is estimated at US$341.2 Million in the year 2020. The country currently accounts for a 35.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$161.4 Million in the year 2027 trailing a CAGR of 14.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.3% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR while Rest of European market (as defined in the study) will reach US$161.4 Million by the year 2027.
In the global Microfluidics-based segment, USA, Canada, Japan, China and Europe will drive the 15.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$139.1 Million in the year 2020 will reach a projected size of US$377.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$186.4 Million by the year 2027.

SELECT PLAYERS

3D Biotek, LLC; Advanced Biomatrix, Inc.; Becton Dickinson and Company; Corning Inc.; Greiner Bio One International GmbH; Hamilton Company; InSphero AG; Lonza Group AG; Merck KGaA; Mimetas B.V.; Nanofiber Solutions; REPROCELL USA Inc.; Synthecon, Incorporated; Tecan Trading AG; Thermo Fisher Scientific Inc.

SEGMENTS

» Product (Scaffold-based, Scaffold-free, Microfluidics-based, Magnetic & Bioprinted) » Application (Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, Tissue Engineering & Regenerative Medicine)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
3D Cell Culture Transforms Life Sciences Industry
3D Cell Culture: An Introduction
3D-Cell Culture Models
Benefits of 3D Cell Culture
Key 3D Cell Culture Formats
3D Cell Culture—Different Techniques
Scaffold-Based 3D Cell Culture
Polymeric Hard Scaffolds
Biological Scaffolds
Micropatterned Surface Microplates
Non-Scaffold Based 3D Cell Culture
Hanging Drop Microplates
Spheroid Microplates with Ultra-Low Attachment (ULA) coating
Microfluidic 3D Cell Culture
Expanding Applications Fuel Growth in the Global 3D Cell Culture Market
Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth
Scaffold-based 3D Cell Culture Products Dominate the Market
Cancer and Stem Cell Research Leads the Global Market
Competitive Scenario
Key Commercial 3D Cell Culture Devices
2. FOCUS ON SELECT PLAYERS
Recent Market Activity
3. MARKET TRENDS & DRIVERS
Rising Incidence of Cancer Drives the Demand for 3D Cell Culture
EXHIBIT 1: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 2: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
EXHIBIT 3: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
Increasing Demand for 3D Cell Culture in Drug Discovery
Use of 3D Cell Culture for Regenerative Medicine
Organoids as Alternatives to Using Animals in Experiments
Use of 3D Cell Culture for Regenerative Medicine
Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges
Technological Advancements Promote 3D Cell Culture Market
Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures
3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
A Review of Research Efforts and Achievements of Companies and Universities
3D Tissue Culture: Growing Significance in Cancer Research
Cells Grown in 3D Change Cell Proliferation and Morphology
Cells Grown in 3D Demonstrate a More Pragmatic Drug Response
Cells Grown in 3D Express Phenotypic Heterogeneity
Cells Grown in 3D Alter Cell Behavior and Gene Expression
Cells Grown in 3D Replicate the Tumor Microenvironment
Other Advantages of 3D Tissue Culture Models
New Dimension of Cell Culture: The Rise of Spheroid Culture Systems
Challenges
Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2020 & 2027
World Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
World Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
World Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
World Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
World Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
World Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
World Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
World 10-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
USA 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
USA Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
USA 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
CANADA
Canada Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Canada 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Canada Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Canada 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
JAPAN
Japan Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Japan 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Japan Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Japan 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
CHINA
China Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
China 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
China Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
China 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
EUROPE
Europe Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Europe 10-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2020 & 2027
Europe Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Europe 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Europe Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Europe 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
FRANCE
France Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
France 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
France Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
France 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
GERMANY
Germany Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Germany 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Germany Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Germany 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
ITALY
Italy Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Italy 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Italy Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Italy 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
UK 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
UK Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
UK 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Rest of Europe 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Rest of Europe Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Rest of Europe 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Asia-Pacific 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Asia-Pacific Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Asia-Pacific 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Rest of World 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027
Rest of World Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR
Rest of World 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027
Total Companies Profiled: 38

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com